Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Account Payables (2017 - 2020)

Fortress Biotech has reported Change in Account Payables over the past 5 years, most recently at -$19000.0 for Q4 2020.

  • Quarterly results put Change in Account Payables at -$19000.0 for Q4 2020, changed N/A from a year ago — trailing twelve months through Mar 2021 was -$6000.0 (up 97.77% YoY), and the annual figure for FY2019 was -$149000.0, down 547.83%.
  • Change in Account Payables for Q4 2020 was -$19000.0 at Fortress Biotech, down from $13000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for FBIO hit a ceiling of $133000.0 in Q1 2019 and a floor of -$298000.0 in Q3 2019.
  • Median Change in Account Payables over the past 4 years was $6000.0 (2018), compared with a mean of -$15400.0.
  • Peak annual rise in Change in Account Payables hit 1700.0% in 2019, while the deepest fall reached 472.5% in 2019.
  • Fortress Biotech's Change in Account Payables stood at $24000.0 in 2017, then tumbled by 116.67% to -$4000.0 in 2018, then crashed by 7350.0% to -$298000.0 in 2019, then skyrocketed by 93.62% to -$19000.0 in 2020.
  • The last three reported values for Change in Account Payables were -$19000.0 (Q4 2020), $13000.0 (Q1 2020), and -$298000.0 (Q3 2019) per Business Quant data.